Page last updated: 2024-08-25

s20098 and Chronic Disease

s20098 has been researched along with Chronic Disease in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Białek, K; Bijak, M; Czarny, P; Gruca, P; Jóźwiak, P; Papp, M; Sliwinski, T; Synowiec, E; Szemraj, J; Wigner, P1
Almeida, OF; Alves, ND; Beckers, J; Bessa, JM; Correia, JS; Irmler, M; Korostynski, M; Machado-Santos, AR; Mateus-Pinheiro, A; Morais, M; Patrício, P; Piechota, M; Pinto, L; Sousa, N; Stoffel, R1
Antonen, EG; Kruchek, MM; Nikitina, MV1
Demirdaş, A; Nazıroğlu, M; Ünal, GÖ1
Goodwin, GM1
Gorwood, P; Le Strat, Y1
Kennedy, SH1
Dagyte, G; De Jager, T; Den Boer, JA; Gabriel, C; Luiten, PG; Mocaër, E; Van der Zee, EA1
Boyer, PA; Gruca, P; Mocaër, E; Papp, M1

Reviews

2 review(s) available for s20098 and Chronic Disease

ArticleYear
Agomelatine, an innovative pharmacological response to unmet needs.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:7 Suppl

    Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Circadian Rhythm; Depressive Disorder, Major; Humans; Models, Animal; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome

2008
Treating each and every depressed patient.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:7 Suppl

    Topics: Acetamides; Age Factors; Antidepressive Agents; Anxiety; Chronic Disease; Circadian Rhythm; Depressive Disorder, Major; Female; Humans; Male; Patient Selection; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Severity of Illness Index; Sex Factors; Sleep; Time Factors; Treatment Outcome

2008

Other Studies

7 other study(ies) available for s20098 and Chronic Disease

ArticleYear
The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures.
    Genes, 2020, 09-18, Volume: 11, Issue:9

    Topics: Acetamides; Acetyltransferases; Animals; Brain; Chronic Disease; DNA Methylation; Gene Expression Regulation; Hypnotics and Sedatives; Indoleamine-Pyrrole 2,3,-Dioxygenase; Leukocytes, Mononuclear; Male; Rats; Rats, Wistar; Stress, Psychological; Tryptophan; Tryptophan Hydroxylase

2020
Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:2

    Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Dentate Gyrus; Depressive Disorder; Disease Models, Animal; Fluoxetine; Gene Expression; Imipramine; Male; Neurons; Random Allocation; Rats, Wistar; Stress, Psychological; Thiazepines; Uncertainty

2015
[Clinical experience of the use of agomelatine in the treatment of patients with depression and chronic brain ischemia].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:12

    Topics: Acetamides; Adult; Anxiety; Brain Ischemia; Chronic Disease; Depression; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep; Sleep Initiation and Maintenance Disorders

2015
Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression.
    Metabolic brain disease, 2016, Volume: 31, Issue:6

    Topics: Acetamides; Animals; Brain; Chronic Disease; Cytokines; Depression; Kidney; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Stress, Psychological

2016
Major depression is sometimes described as the common cold of psychiatry.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:7 Suppl

    Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Circadian Rhythm; Depressive Disorder, Major; Humans; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome

2008
Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain.
    Journal of neuroscience research, 2011, Volume: 89, Issue:10

    Topics: Acetamides; Animals; Antidepressive Agents; Brain Chemistry; Chronic Disease; Depressive Disorder; Disease Models, Animal; Male; Rats; Rats, Wistar; Stress, Psychological; Synapsins

2011
Effect of agomelatine in the chronic mild stress model of depression in the rat.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:4

    Topics: Acetamides; Animals; Antidepressive Agents; Chronic Disease; Chronotherapy; Depression; Disease Models, Animal; Male; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Receptors, Serotonin; Stress, Physiological

2003